SENS News and Press, Senseonics Holdings Inc. From 05/24/23

2023-05-24 13:57:04 ET The Russell 3000 index will have a new look on June 26, after the market opens, when 286 securities will be added and 179 securities will be deleted as part of the annual reconstitution. Following are some notable healthcare companies which will be added an...

2023-05-24 13:33:04 ET In its preliminary annual 2023 Russell indexes reconstitution, a total of 164 companies will be added and 319 deleted from the Russell microcap index. Following notable healthcare companies will be added and deleted from Russell microcap index: Notable additio...

2023-05-16 18:49:10 ET Summary Plenty of initiatives are afoot in Senseonics to grow the business and open up access to Eversense in a significant way. The market though remains unconvinced. Better sales growth is needed to really move the needle here. The company is still not...

2023-05-09 18:36:08 ET Senseonics Holdings, Inc. (SENS) Q2 2023 Earnings Conference Call May 9, 2023, 04:30 PM ET Company Participants Philip Taylor - IR Tim Goodnow - President and CEO Rick Sullivan - CFO Mukul Jain - COO Conference Call Participants ...

2023-05-09 16:23:05 ET Senseonics press release ( NYSE: SENS ): Q1 GAAP EPS of $0.00 beats by $0.03 . Revenue of $4.14M (+66.9% Y/Y) beats by $0.77M . U.S. revenue was $2.1 million in the first quarter of 2023 compared to $0.8 million in the prior year per...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended March 31, 2023. R...

2023-05-08 15:20:06 ET The basic definition of penny stocks includes shares of public companies priced under $5. While some traders might argue that they are exclusive to the Over-The-Counter or “OTC exchange,” the truth is that numerous low-priced stocks can also be found on ...

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its first quarter 2023 financial resul...

ASCENSIA DIABETES CARE MARKS ONE-YEAR ANNIVERSARY OF US EVERSENSE E3 CGM LAUNCH WITH COMMERCIAL UPDATE AND INNOVATION OUTLOOK PR Newswire PARSIPPANY, N.J. , April 24, 2023 /PRNewswire/ -- Ascensia Diabetes Care , a global diabetes care company, maker of the CONTOUR ...

Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the first pediatric study participant has been inserted with E...